Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207. (Q44190152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Jose M Arencibia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Ana M. Bajo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Magdalena Krupa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Ioulia Chatzistamou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Attila Nagy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

949-956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

14 December 2019

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

HER2/neu: mechanisms of dimerization/oligomerization

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Cancer statistics, 1999.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Prognostic significance of c-erB-2 mRNA in ovarian carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200210000-00007

Identifiers

DOI

10.1097/00001813-200210000-00007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12394258%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference